幽门螺杆菌治疗适应证与评价
摘要
有关幽门螺杆菌(Helicobacter pylori,Hp)治疗的适应证随着学者们对Hp致病的不断深入了解,对Hp发病机制和病理生理的深入研究,Hp耐药菌株的出现,在治疗上也随着认识的提高,强调个体化治疗,使得Hp治疗的适应证和治疗方案也不断更新。
出处
《中国医师进修杂志》
2014年第7期6-8,共3页
Chinese Journal of Postgraduates of Medicine
二级参考文献24
-
1Wotherspoon AC,Ortiz-Hidalgo C,Falzon MR,Isaacson PG. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma. Lancet 1991; 338: 1175-1176.
-
2Parsonnet J,Hansen S,Rodriguez L,Gelb AB,Warnke RA, Jellum E,Orentreich N,Vogelman JH,Friedman GD. He- licobacter pylori infection and gastric lymphoma. N Engl J Med 1994; 330: 1267-1271.
-
3Eck M,Schmausser B,Haas R,Greiner A,Czub S,Müller- Hermelink HK. MALT-type lymphoma of the stomach is associated with Helicobacter pylori strains expressing the CagA protein. Gastroenterology 1997; 112: 1482-1486.
-
4Sagaert X,Van Cutsem E,De Hertogh G,Geboes K, Tousseyn T. Gastric MALT lymphoma: a model of chronic inflammation-induced tumor development. Nat Rev Gastro- enterol Hepatol 2010; 7: 336-346.
-
5Bonizzi G,Karin M. The two NF-kappaB activation path- ways and their role in innate and adaptive immunity. Trends Immunol 2004; 25: 280-288.
-
6Zullo A,Hassan C,Andriani A,Cristofari F,De Francesco V, Ierardi E,Tomao S,Morini S,Vaira D. Eradication therapy for Helicobacter pylori in patients with gastric MALT lym- phoma: a pooled data analysis. Am J Gastroenterol 2009; 104: 1932-1937; quiz 1938.
-
7Zucca E,Dreyling M. Gastric marginal zone lymphoma of MALT type: ESMO clinical recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008; 19 Suppl 2: ii70- ii71.
-
8Ye H,Liu H,Attygalle A,Wotherspoon AC,Nicholson AG, Charlotte F,Leblond V,Speight P,Goodlad J,Lavergne- Slove A,Martin-Subero JI,Siebert R,Dogan A,Isaacson PG, Du MQ. Variable frequencies of t(11; 18)(q21; q21) in MALT lymphomas of different sites: significant association with CagA strains of H pylori in gastric MALT lymphoma. Blood 2003; 102: 1012-1018.
-
9Alpen B,Neubauer A,Dierlamm J,Marynen P,Thiede C, Bayerd rfer E,Stolte M. Translocation t(11; 18) absent in early gastric marginal zone B-cell lymphoma of MALT type responding to eradication of Helicobacter pylori infection. Blood 2000; 95: 4014-4015.
-
10Sugiyama T,Asaka M,Nakamura T,Nakamura S,Yonezu- mi S,Seto M. API2-MALT1 chimeric transcript is a predic- tive marker for the responsiveness of H. pylori eradication treatment in low-grade gastric MALT lymphoma. Gastroen- terology 2001; 120: 1884-1885.
共引文献6
-
1龚宇华,潘炜娟,魏本娟,郁利,虢灿杰.胃幽门螺杆菌感染与口臭的相关性研究[J].现代生物医学进展,2015,15(1):66-68. 被引量:9
-
2杨舒,张雷.幽门螺旋杆菌致病与免疫机制的研究进展[J].中国病原生物学杂志,2017,12(3):283-285. 被引量:20
-
3彭铮.比较两种用药联合治疗幽门螺杆菌感染后的Hp根除率效果探究[J].当代医学,2018,24(9):114-115.
-
4吴春香.人幽门螺杆菌感染与养宠相关性的研究进展[J].当代畜牧,2022(8):50-51.
-
5许逸风,邓闻宣,李钰,尹列芬.原发性胃肠道淋巴瘤病理分型及诊治进展[J].黑龙江医学,2024,48(7):895-896.
-
6Marta-Isabel Pereira,José Augusto Medeiros.Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas[J].World Journal of Gastroenterology,2014,20(3):684-698. 被引量:8
-
1余波.盐酸多奈哌齐治疗老年性痴呆的临床疗效观察[J].中国现代药物应用,2012,6(18):103-104. 被引量:9
-
2周小华,黄金根,黄智勇,李跃程.出血性脑卒中330例临床分析[J].中国当代医药,2010,17(5):26-26. 被引量:2
-
3赵晓东.奥扎格雷钠联合阿司匹林、低分子肝素治疗进展性脑梗死的临床疗效分析[J].临床医药文献电子杂志,2014,1(15):1980-1980. 被引量:4
-
4黄长荣.82例老年性痴呆患者应用盐酸多奈哌齐治疗的临床研究[J].中国保健营养(下半月),2013,0(8):2029-2029. 被引量:2
-
5李振,苏永立,乔清涛.针灸及穴位注射治疗面肌痉挛107例临床观察[J].甘肃中医,2008,21(5):31-31. 被引量:6
-
6贾琳琳.阿司匹林联合氯吡格雷治疗脑卒中患者的临床疗效观察[J].中国民康医学,2015,27(19):46-47. 被引量:3
-
7綾部純一,刘芳.脑卒中急性期的外科治疗[J].日本医学介绍,2006,27(3):130-131.
-
8韩强,李胜林.微创穿刺术与小骨窗血肿清除术治疗高血压脑出血的临床对照研究[J].医学综述,2012,18(21):3702-3704. 被引量:23
-
9高子斌,薛秋玉.癫痫外科治疗适应证[J].医学信息,2009,22(3):365-365.
-
10杨冰,陈衔城,吴劲松,潘力,戴嘉中,王滨江,张卫军.脑动静脉畸形的伽玛刀治疗[J].中国微侵袭神经外科杂志,2002,7(4):210-213. 被引量:9